We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DB function failed with error number 0

AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG

More...
11 Oct 2026
DB function failed with error number 0

Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

More...
11 Oct 2026
Image Credit: Adobe Stock

Blood-Based Immune Signal Could Reveal Lung Cancer Risk Before Tumors Develop

New findings demonstrate a blood-based immune signal that may indicate lung cancer risk years before a tumor develops. More...
09 Oct 2026
Image: Overview of the multiple-instance learning (MIL) workflow, in which each TMA core image is represented as a bag of patches that are encoded and aggregated to generate a slide-level prediction. (Giner F, Pastor-Naranjo Á, Meseguer P, et al. International Journal of Molecular Sciences, 2026. DOI: 10.3390/ijms27156864)

AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis

An AI approach analyzes digitized histology to distinguish Ewing sarcoma from similar tumors with 97% sensitivity, guiding workup. More...
09 Oct 2026
Image: Neonatal sepsis research team with Hon Stephen Dawson WA Minister for Science and Innovation; Medical Research. (Photo courtesy of Murdoch University)

Prototype Point-of-Care Test Aims to Improve Neonatal Sepsis Diagnosis

A new point-of-care test using four biomarkers targets over 95% accuracy for neonatal sepsis at first suspicion vs 60%. More...
09 Oct 2026
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

New data show genomic newborn screening augments standard tests by detecting missed treatable conditions earlier. More...
09 Oct 2026
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix and Innovita announced Chinese regulatory approvals for SIMOA technology and neurology biomarker testing. More...
09 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Automatic CLIA Analyzer
Shine i6000
Copyright © 2000-2026 Globetech Media. All rights reserved.